biotech
biotech Articles
Selecta Biosciences and Sarepta Therapeutics have announced that they had entered into a research license and option agreement.
Published:
Alpine Immune Sciences shares doubled on Thursday after the company announced a license agreement with AbbVie for its ALPN-101.
Published:
Aclaris Therapeutics has received an update from FDA regarding the use of its ATI-450 in hospitalized patients with COVID-19.
Published:
Canaccord Genuity recently released a report detailing some of the biggest biotech catalysts coming out over these next six months.
Published:
Curis shares jumped on Wednesday after the company announced a critical update from the FDA.
Published:
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
The day traders are back at it, chasing stocks on news with very few thoughts about what the fundamentals may be if the good news pans out. In day trading, that just doesn’t matter because a trade...
Published:
Enochian Biosciences shares more than doubled to start out the week after the company received a critical update from the FDA regarding its HIV treatment.
Published:
FSD Pharma shares absolutely exploded on Wednesday morning after the company received a key update from the FDA.
Published:
Brokerage firm Canaccord Genuity issued some key takeaways on a few different companies at ASCO. 24/7 Wall St. has also included some recent data on the stock.
Published:
Intellia Therapeutics shares rallied after it announced an expansion to its collaboration with Regeneron Pharmaceuticals.
Published:
Phio Pharmaceuticals shares more than doubled on Friday after the firm announced positive data from its cancer study at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific...
Published:
Adaptimmune Therapeutics shares jumped on Friday after the company announced updated data from its early-stage clinical trial in patients with lung, head and neck cancers.
Published:
PhaseBio Pharmaceuticals shares jumped early on Thursday after the company announced that it received an authorization from the FDA regarding its COVID-19 treatment.
Published:
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
Published: